{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T16:40:25Z","timestamp":1720975225853},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Rationale:<\/jats:title><jats:p>Angiotensin receptor blocker (ARB) can increase serum creatinine or potassium levels in patients with renal insufficiency, renal artery stenosis, heart failure or hypovolemia, but hardly cause severe kidney injury in patients without any risk factors. A case of severe acute interstitial nephritis (AIN) induced by valsartan was reported here.<\/jats:p><\/jats:sec><jats:sec><jats:title>Patient concerns:<\/jats:title><jats:p>A 62-year-old female with nausea for 1 month and acute deterioration of kidney function for 2 weeks was admitted. She had a history of hypertension for 5 months and had taken valsartan 40\u200amg daily for 4 months. Although the valsartan had been stopped for 2 weeks, the serum creatinine continuously increased after admission. Kidney biopsy demonstrated the eosinophils infiltration in interstitium.<\/jats:p><\/jats:sec><jats:sec><jats:title>Diagnoses:<\/jats:title><jats:p>AIN induced by valsartan.<\/jats:p><\/jats:sec><jats:sec><jats:title>Interventions:<\/jats:title><jats:p>The patient was treated with glucocorticoid.<\/jats:p><\/jats:sec><jats:sec><jats:title>Outcomes:<\/jats:title><jats:p>The serum creatinine decreased gradually and got back to normal level 5 months later. Then therapy of glucocorticoid was stopped. Renal artery stenosis was excluded by computed tomography angiography (CTA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Lessons:<\/jats:title><jats:p>Although valsartan-induced allergy has been reported previously, AIN was firstly recognized as a severe complication of this drug. We suggest when there is a ARB-associated continuous deterioration of kidney function for patients without renal insufficiency, renal artery stenosis, heart failure or hypovolemia, AIN should be thought of and therapy with glucocorticoid should be considered if necessary.<\/jats:p><\/jats:sec>","DOI":"10.1097\/md.0000000000014428","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T08:56:52Z","timestamp":1549529812000},"page":"e14428","source":"Crossref","is-referenced-by-count":2,"title":["Severe acute interstitial nephritis induced by valsartan"],"prefix":"10.1097","volume":"98","author":[{"given":"Tong","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Hematology, Tianjin Medical University General Hospital, Tianjin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-cheng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tianjin Medical University General Hospital, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shui-yi","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tianjin Medical University General Hospital, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tie-kun","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tianjin Medical University General Hospital, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Qing","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tianjin Medical University General Hospital, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ya","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tianjin Medical University General Hospital, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tianjin Medical University General Hospital, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-ya","family":"Shang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Tianjin Medical University General Hospital, Tianjin, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3892\/ijmm.2016.2525","article-title":"Valsartan ameliorates podocyte loss in diabetic mice through the Notch pathway","volume":"37","author":"Gao","year":"2016","journal-title":"Int J Mol Med"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"j791","DOI":"10.1136\/bmj.j791","article-title":"Serum creatinine elevation after renin-angiotensin system blockade and long term cardiorenal risks: cohort study","volume":"356","author":"Schmidt","year":"2017","journal-title":"BMJ"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"e005428","DOI":"10.1161\/JAHA.116.005428","article-title":"Hyperkalemia after initiating renin-angiotensin system blockade: the Stockholm Creatinine Measurements (SCREAM) Project","volume":"6","author":"Bandak","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/0036933013482634","article-title":"Monitoring and adverse events in relation to ACE inhibitor\/angiotensin receptor blocker initiation in people with diabetes in general practice: a population database study","volume":"58","author":"Mathieson","year":"2013","journal-title":"Scott Med J"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/jch.13097","article-title":"Angiotensin-converting enzyme inhibitor-induced angioedema: a review of the literature","volume":"19","author":"Brown","year":"2017","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"R6-20230914","first-page":"63","article-title":"Angiotensin receptor blocker-induced visceral angioedema","volume":"25","author":"Thalanayar","year":"2015","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000167970","article-title":"Captopril-associated acute interstitial nephritis","volume":"9","author":"Smith","year":"1989","journal-title":"Am J Nephrol"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0140-6736(05)65136-7","article-title":"Losartan-associated atypical cutaneous lymphoid hyperplasia","volume":"350","author":"Viraben","year":"1997","journal-title":"Lancet"},{"key":"R9-20230914","first-page":"1040","article-title":"Severe pustular and polymorphous vasculitis caused by losartan","volume":"128","author":"Pi\u00e9rard Franchimont C1","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"R10-20230914","first-page":"685","article-title":"Losartan associated anaphylaxis and angioneurotic oedema","volume":"60","author":"Kazim","year":"2010","journal-title":"J Pak Med Assoc"},{"key":"R11-20230914","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00000372-200308000-00008","article-title":"Lymphomatoid drug eruption mimicking digitate dermatosiscross reactivity between two drugs that suppress angiotensin II function","volume":"25","author":"Mustasim","year":"2003","journal-title":"Am J Dermatopathol"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1111\/j.1365-2230.2009.03283.x","article-title":"Linear lichenoid drug eruption induced by valsartan","volume":"34","author":"Gencoglan","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2340\/00015555-0695","article-title":"Valsartan-induced drug eruption followed by CD30+ pseudolymphomatous eruption","volume":"90","author":"Sawada","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/15569527.2011.647179","article-title":"Exanthematous drug eruption due to valsartan","volume":"31","author":"Ozturk","year":"2012","journal-title":"Cutan Ocul Toxicol"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/j.1875-9114.1998.tb03912.x","article-title":"Angioedema and photosensitive rash induced by valsartan","volume":"18","author":"Frye","year":"1998","journal-title":"Pharmacotherapy"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0025-7753(00)71374-1","article-title":"Angioedema and urticarial reaction induced by valsartan","volume":"114","author":"de la Serna Higuera","year":"2000","journal-title":"Med Clin"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1034\/j.1398-9995.2003.00064_1.x","article-title":"Angioedema due to valsartan","volume":"58","author":"Mart\u00ednez Alonso","year":"2003","journal-title":"Allergy"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1345\/aph.1C520","article-title":"Valsartan-induced angioedema","volume":"37","author":"Irons","year":"2003","journal-title":"Ann Pharmacother"},{"key":"R19-20230914","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjoto.2010.11.014","article-title":"Angiotensin II receptor blocker-induced angioedema in the oral floor and epiglottis","volume":"32","author":"Shino","year":"2011","journal-title":"Am J Otolaryngol"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1097\/MJT.0b013e3181f28f84","article-title":"Valsartan-induced angioedema in a patient on angiotensin-converting enzyme inhibitor for years: case report and literature review","volume":"19","author":"Kalra","year":"2012","journal-title":"Am J Ther"},{"key":"R21-20230914","first-page":"187","article-title":"Mucocutaneous bullous pemphigoid induced by valsartan. A clinical case","volume":"52","author":"Femiano","year":"2003","journal-title":"Minerva Stomatol"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/ccr3.1456","article-title":"Acute interstitial nephritis: a multifaceted disease","volume":"6","author":"Chamarthi","year":"2018","journal-title":"Clin Case Rep"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/j.ackd.2016.11.004","article-title":"Mechanisms of drug-induced interstitial nephritis","volume":"24","author":"Raghavan","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2215\/CJN.01390118","article-title":"Duration of treatment with corticosteroids and recovery of kidney function in acute interstitial nephritis","volume":"13","author":"Fernandez-Juarez","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4103\/1319-2442.235171","article-title":"Drug-induced acute interstitial nephritis: prospective randomized trial comparing oral steroids and high-dose intravenous pulse steroid therapy in guiding the treatment of this condition","volume":"29","author":"Chowdry","year":"2018","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.ackd.2016.11.016","article-title":"Medication-induced interstitial nephritis in the 21st Century","volume":"24","author":"Nast","year":"2017","journal-title":"Adv Chronic Kidney Dis"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.2215\/CJN.12001018","article-title":"Treatment of drug-induced acute tubulointerstitial nephritis: the search for better evidence","volume":"13","author":"Moledina","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R28-20230914","article-title":"The effectiveness of corticosteroid compared to non-corticosteroid therapy for the treatment of drug-induced acute interstitial nephritis: a systematic review","author":"Quinto","year":"2018","journal-title":"Intern Med J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201902080-00082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T16:15:42Z","timestamp":1720973742000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201902080-00082"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014428","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}